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Résumé en
anglais
Nanoparticles of biocompatible and biodegradable polymers such as poly-lactic-co-
glycolic acid (PLGA) are widely used as drug delivery systems for the
administration of biomolecules like proteins. The purpose of this work is to validate
a novel formulation method by a phase separation phenomenon using the non-toxic
solvent glycofurol (GF) in order to encapsulate proteins into PLGA nanoparticles.
Nanoprecipitates of a model protein (lysozyme) and a therapeutic protein (TGF-β1)
were formed to ensure their stability upon subsequent encapsulation in PLGA
nanoparticles.
Good encapsulation efficiency was obtained with preservation of the structure
integrity and protein bioactivity after encapsulation. PLGA nanoparticles were then
characterized in terms of size, zeta potential and morphology. Moreover, residual
solvent was quantified and in vitro release study of the encapsulated proteins was
performed to demonstrate the efficacy of our encapsulation method in drug
sustained release. Finally, cytocompatibility study of nanoparticles was performed.
Thus, we developed an effective method based on the preliminary step of protein
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